Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4378)
All Articles published online
|
Publishing Process of This Article
|
Jan 6, 2021 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lu YL, Chen ST, Ho TY, Chan WH, Wong RJ, Hsueh C, Lin SF. Primary lung cancer with radioiodine avidity: A thyroid cancer cohort study. World J Clin Cases 2021; 9(1): 71-80 [PMID: 33511173 DOI: 10.12998/wjcc.v9.i1.71] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v9/i1/71.htm |
| Number | Citing Articles |
| 1 |
Ming-Hsien Wu, Yi-Yin Lee, Yu-Ling Lu, Shu-Fu Lin. Risk Factors and Prognosis for Metastatic Follicular Thyroid Cancer. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.791826
|
| 2 |
Cristina Basso, Alessandra Colapinto, Valentina Vicennati, Alessandra Gambineri, Carla Pelusi, Guido Di Dalmazi, Elisa Lodi Rizzini, Elena Tabacchi, Arber Golemi, Letizia Calderoni, Stefano Fanti, Uberto Pagotto, Andrea Repaci. Radioiodine whole body scan pitfalls in differentiated thyroid cancer. Endocrine 2024; doi: 10.1007/s12020-024-03754-y
|
| 3 |
Jian Zhou, Tengyong Wang, Liang Xia, Quan Zheng, Dongsheng Wu, Mingying Lin, Tianyi Lu, Lin Ma. Effect of a prior thyroid cancer on the survival of lung cancer patients: a retrospective study based on SEER database. Endocrine 2023; 83(1): 142 doi: 10.1007/s12020-023-03474-9
|
| 4 |
Chia-Jung Hsu, Kun-Yu Lai, Yu-Ling Lu, Ming-Hsien Wu, Feng-Hsuan Liu, Shu-Fu Lin. Outcomes of Patients With Metastatic Differentiated Thyroid Cancer After Excellent Response to Treatment. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.923182
|